Tandem Diabetes Care, Inc. TNDM is well-poised for growth in the coming quarters due to its series of innovative product offerings, which continue to generate remarkable enthusiasm. Moreover, the t:slim X2 with Control-IQ technology continues to stand out as the number-one rated automated insulin delivery system, as evidenced by third-party research and the company’s internal customer satisfaction surveys. The resulting effects of these macroeconomic factors, along with high inflation, have led to the disruption of the company’s relationship with suppliers, third-party manufacturers, healthcare providers, distributors and overall customers.